57.71 -0.43 (-0.74%)
DGX
| Trade DGX now with |
Stock Details
Last Trade:57.71 Change:-0.43 (-0.74%) Prev Close:58.14 Open: 58.10 Days Range:57.42 – 58.15 52 Week Range: 45.13 - 61.47 Volume:774540 P/E: 19.70EPS:2.93
View AllRecent Alerts 02/09/12
Recent Alert on 02/09/12 at 1:45pm
Auriga Reiteratess a 'Hold' on Laboratory Corporation (LH); Expect In-line to Slightly Better 4Q Results
Auriga Reiteratess a 'Hold' on Laboratory Corporation (LH); Expect In-line to Slightly Better 4Q Results
Auriga reiteratess a 'Hold' on Laboratory Corporation of America (NYSE: LH) price target of $91.00. Auriga analyst says, "Based on recent results by LH’s largest peer Quest Diagnostics (NYSE: DGX)(Hold Rated) there is a strong possibility that... Read More
Recent Alert on 02/09/12 at 1:45pm
Auriga Reiteratess a 'Hold' on Laboratory Corporation (LH); Expect In-line to Slightly Better 4Q Results
Auriga Reiteratess a 'Hold' on Laboratory Corporation (LH); Expect In-line to Slightly Better 4Q Results
Recent Alert on 01/25/12 at 11:05am
Auriga Reiterates a 'Hold' on Quest Diagnostics (DGX); 4Q11: A Solid Quarter with Cost Management Highlighted
Auriga Reiterates a 'Hold' on Quest Diagnostics (DGX); 4Q11: A Solid Quarter with Cost Management Highlighted
Recent Alert on 01/24/12 at 7:08am
Quest Diagnostics, Inc. (DGX) Tops Q4 EPS by 17c, Posts Weak FY12 EPS Guidance
Quest Diagnostics, Inc. (DGX) Tops Q4 EPS by 17c, Posts Weak FY12 EPS Guidance
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/09/12 at 5:01pm
Form SC 13G QUEST DIAGNOSTICS INC Filed by: BARROW HANLEY MEWHINNEY & STRAUSS LLC
Form SC 13G QUEST DIAGNOSTICS INC Filed by: BARROW HANLEY MEWHINNEY & STRAUSS LLC
SEC Filing on 02/07/12 at 4:06pm
Form 4 QUEST DIAGNOSTICS INC For: Feb 03 Filed by: Miller Joan Elizabeth
Form 4 QUEST DIAGNOSTICS INC For: Feb 03 Filed by: Miller Joan Elizabeth
View AllRecent Blog Posts
Blog Posts on 01/24/12 at 3:50pm
Quest Diagnostics' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Quest Diagnostics' CEO Discusses Q4 2011 Results - Earnings Call Transcript


